← Back to headlines
Dyne Therapeutics Shares Decline After $375 Million Public Offering
Shares of Dyne Therapeutics experienced a slide following the pricing of its $375 million public offering.
22 Jul, 12:29 — 22 Jul, 12:29
Sources
Showing 1 of 1 sources

